Mobile Menu

Search Results

Search results for: Precision Medicine

Liquid Biopsy ONLINE 2020 Webinar Series

As we continue to improve our understanding of cancer biology, one thing remains a game-changer for cancer care: the ability […]

The human endometrium at a single-cell level

Researchers have characterised the transcriptomic transformation of the human endometrium during the menstrual cycle at single-cell resolution.  Human endometrium During […]

Experts say gene editing is too risky

An international commission has stated that we need more research before gene editing can be used in babies and for […]

CRUK forms a new partnership to develop a head and neck cancer vaccine

Cancer Research UK (CRUK), the University of Southampton and the London-based biotechnology company Touchlight Genetics have announced a new partnership […]

The benefits of using genomics in clinical trials

Genomics has the potential to improve efficacy of drugs and accelerate precision healthcare, but one area with the biggest potential […]

Marketing Best-Practices During COVID-19. Building Success During Uncertainty

I recently interviewed marketing veteran Jeff Daniels on how organisations can overcome revenue hurdles during COVID-19. The following article summarises […]

Genomics against COVID-19: A summary

Last week, we asked the genomics community how they were shifting their focus to help fight the novel coronavirus. We […]

FDA releases list of evidence-based pharmacogenetic variants

Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.